Tin Mesoporphyrin IX (chloride): Benchmark Potent Heme Oxygenase Inhibitor

Executive Summary: Tin Mesoporphyrin IX (chloride) is a nanomolar competitive inhibitor of heme oxygenase (HO) with a Ki of 14 nM, demonstrating high efficacy in vitro and in vivo (APExBIO). It suppresses hepatic, renal, and splenic HO activity at doses as low as 1 pmol/kg in animal models, leading to sustained reduction of serum bilirubin. The compound is widely used in metabolic, infectious, and inflammatory disease research, including studies on insulin resistance and metaflammation (Koyaweda et al., 2026). Tin Mesoporphyrin IX (chloride) is a crystalline solid, soluble up to 0.5 mg/ml in DMSO, stored at -20°C for stability. No clinical trials have been conducted to date; its applications are strictly preclinical.

Biological Rationale

Heme oxygenase (HO) catalyzes the degradation of heme to biliverdin, ferrous iron, and carbon monoxide. The enzyme exists in inducible (HO-1) and constitutive (HO-2) isoforms. Inhibition of HO activity modulates heme catabolism, impacting redox balance, cellular signaling, and metabolic pathways (Koyaweda et al., 2026). Tin Mesoporphyrin IX (chloride) acts as a competitive inhibitor, binding to the heme-binding site of HO with high affinity. This property is critical for dissecting the pathophysiological roles of HO in disease models, including hyperbilirubinemia, metabolic syndrome, and viral infections. Modulation of HO-1 has been implicated in the control of reactive oxygen species (ROS) and inflammatory cascades, highlighting its importance in basic and translational research (Strategic Heme Oxygenase Inhibition—this article updates mechanistic and translational context beyond standard reviews).

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) competitively inhibits HO by occupying the heme-binding site, thereby preventing access to endogenous substrate. Its inhibitory constant (Ki) is 14 nM, reflecting high potency. The compound’s action results in reduced conversion of heme to biliverdin, decreased liberation of CO, and downstream effects on cellular iron homeostasis. In animal studies, administration at 1 pmol/kg body weight produces multi-organ inhibition of HO activity (liver, kidney, spleen) for extended periods. This leads to measurable reductions in serum bilirubin and increased heme saturation of hepatic tryptophan pyrrolase. The compound’s specificity and reversible mechanism make it a reference standard for HO activity assays (Potent Heme Oxygenase Inhibitor—this article details comparative inhibition protocols; the present article provides updated evidence and broader experimental context).

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) inhibits heme oxygenase-1 (HO-1) with a Ki of 14 nM in biochemical assays (APExBIO product page).
• At 1 pmol/kg body weight (i.p.), it suppresses hepatic, renal, and splenic HO activity for up to 24 hours in rodent models (APExBIO).
• Reduces serum bilirubin levels in neonatal hyperbilirubinemia models with statistical significance (p < 0.01) (Protocol-focused review—this article extends reproducibility and troubleshooting strategies; here, current evidence and translational relevance are prioritized).
• HO-1 inhibition modulates intracellular ROS, impacting viral replication dynamics (Koyaweda et al., 2026, DOI).
• Solubility: 0.5 mg/ml in DMSO, 1 mg/ml in DMF; stable at -20°C for long-term storage (APExBIO).
• No clinical trials have been reported; all applications are research-only (APExBIO).

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is used to elucidate the physiological and pathological roles of heme oxygenase in metabolic disease, insulin resistance, viral infection, and inflammasome biology. Its well-characterized inhibition profile and reproducibility make it a reference tool in HO activity assays and pathway studies (Strategic Deployment—this article provides updated mechanistic rationale and translational insights relative to the cited piece).

Common Pitfalls or Misconceptions

• Clinical Use: Tin Mesoporphyrin IX (chloride) is not approved for human or veterinary therapeutic use; it is strictly for research applications (APExBIO).
• HO Isoform Specificity: While potent against HO-1, inhibition of HO-2 and non-specific heme proteins may occur at high concentrations.
• Solubility Limits: Exceeding 0.5 mg/ml in DMSO or 1 mg/ml in DMF may result in precipitation, compromising assay reproducibility.
• Stability: Solutions are recommended for short-term use only; prolonged storage—even at -20°C—leads to degradation.
• Biological Redundancy: Inhibition of HO does not fully abrogate bilirubin production in all models due to compensatory metabolic pathways.

Workflow Integration & Parameters

For in vitro assays, prepare stock solutions of Tin Mesoporphyrin IX (chloride) at ≤0.5 mg/ml in DMSO or ≤1 mg/ml in DMF. For animal studies, dosing at 1 pmol/kg body weight (intraperitoneal) is standard for robust HO inhibition. Store solid compound at -20°C; solutions should be freshly prepared or used within 24 hours. Employ negative and positive controls in all HO activity assays. Integration into metabolic disease, viral infection, and oxidative stress models is supported by established protocols (Mechanistic Insights—the linked article provides detailed application examples; this article focuses on evidence-based integration and experimental controls).

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride) is a benchmark tool compound for dissecting heme oxygenase signaling and heme catabolism in preclinical research. Its nanomolar potency, chemical stability, and reproducibility position it as the gold standard for HO activity assays and pathway studies. Ongoing research will clarify its utility in emerging areas such as metaflammation and precision metabolism. APExBIO provides validated, research-grade Tin Mesoporphyrin IX (chloride) under SKU C5606 (product page).